arrow
H

Hyung-Don Kim

university of ulsan
H指数:23
被引数:2,728

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumors

Beamion PANTUMOR-1: Zongertinib二线临床试验的试验依据与设计,用于HER2过表达/扩增或HER2突变的实体瘤

2026-03-040
PRE
Multicenter phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab

多中心II期临床试验,评估仑伐替尼在经一线阿替利珠单抗联合贝伐珠单抗治疗后进展的晚期肝细胞癌患者中的应用。

2025-09-040
OAAI
Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline)

韩国胃癌实践指南2024: 基于证据的多学科方法 (更新2022年指南)

2025-01-012
PRE
Impact of Etiology on Efficacy Outcomes with Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Retrospective Analysis in Asia-Pacific

病因学对晚期肝细胞癌患者阿特珠单抗联合贝伐单抗疗效结局的影响: 亚太地区的跨国回顾性分析

2024-10-030
PRE
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as a Potential Biomarker for Immune Checkpoint Inhibitors in Patients with Biliary Tract Cancer
2024-08-161
PRE